Dr Sue Ring
Phd in Genetics, BSc(hons) in Genetics
Expertise
I have extensive experience of managing biosample and genetic resources for population cohort studies. This includes governance, laboratory management, sample collection and analysis, biobanking and Human Tissue Act compliance.
Current positions
Honorary Senior Research Fellow
Bristol Medical School (PHS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Biography
I am Director of the Bristol Bioresource Laboratories (BBL) and Executive Director (Bioresource) of the Avon Longitudinal Study of Parents and Children (ALSPAC) and a biobanking expert. I have over 25 years of experience of managing sample resources for epidemiological studies.
I established the DNA and lymphoblastoid cell line banks for the ALSPAC and 1958 National Child Development birth cohort studies which have been widely used by the research community across the world and this lead to the development of the Bristol Bioresource Laboratories (https://www.bristol.ac.uk/population-health-sciences/research/groups/bblabs/)
BBL supports a large proportion of research in ALSPAC and Population Health Science at the University of Bristol. The laboratories are custodians of over 2 million samples from several cohort studies including ALSPAC, the 1946, 1958 1970, Millennium and Born in Bradford birth cohorts and clinical collections such as the Cleft Collective and Head and Neck 5000. The laboratories also provide a DNA extraction and genotyping service.
Research Governance and HTA compliance is an important part of my role. I have been a Human Tissue Authority Designated Individual (HTA DI) since 2006 and am currently chair of the University's Human Tissue Working Group, working with colleagues to ensure HTA compliance across the University.
I established the DNA and lymphoblastoid cell line banks for the ALSPAC and 1958 National Child Development birth cohort studies which have been widely used by the research community across the world and this lead to the development of the Bristol Bioresource Laboratories (https://www.bristol.ac.uk/population-health-sciences/research/groups/bblabs/)
BBL supports a large proportion of research in ALSPAC and Population Health Science at the University of Bristol. The laboratories are custodians of over 2 million samples from several cohort studies including ALSPAC, the 1946, 1958 1970, Millennium and Born in Bradford birth cohorts and clinical collections such as the Cleft Collective and Head and Neck 5000. The laboratories also provide a DNA extraction and genotyping service.
Research Governance and HTA compliance is an important part of my role. I have been a Human Tissue Authority Designated Individual (HTA DI) since 2006 and am currently chair of the University's Human Tissue Working Group, working with colleagues to ensure HTA compliance across the University.
Projects and supervisions
Research projects
ALSPAC Renewal 2024 to 2029
Principal Investigator
Role
Co-Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/08/2024 to 31/07/2029
ALSPAC_B3853 _Shaheen_heavy_metals_in ALSPAC and BIB. Is exposure to toxic metals contributing to ethnic and social health inequalities in children and young adults in the UK?
Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/04/2023 to 31/03/2026
Supply of BIB samples for WES - option 2 (BBL costs)
Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/04/2023 to 31/03/2024
The Avon Longitudinal Study of Parents and Children (ALSPAC): A multi-generation, longitudinal resource focusing on life course health and well-being
Principal Investigator
Role
Co-Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/08/2019 to 01/07/2024
8073 MRC via LSHTM; WABR Collab
Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/03/2018 to 28/03/2019
Publications
Recent publications
30/01/2026Airway microbiota in young people across four continents differ by country, asthma status and inflammatory phenotype
Thorax
Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants
Journal of Infectious Diseases
Untargeted metabolomics data in the By-Band-Sleeve trial and ALSPAC
Wellcome Open Research
Behavioural, psychiatric, and cognitive phenotypes associated with numbers of repeats of the FRAXE allele on the FMR2 gene.
Wellcome Open Research
Inflammation proteomics datasets in the ALSPAC cohort
Wellcome Open Research



